The 2015 Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma: the "evidence-based" refusal to endorse them by EANM due to the "not evidence-based" marginalization of the role of Nuclear Medicine.

导出原文传递

翻译打印收藏纠错

作者： Giorgio,Treglia ^[1] ; Cumali,Aktolun ^[2] ; Arturo,Chiti ^[3] ; Savvas,Frangos ^[4] ; Luca,Giovanella ^[5] ; Martha,Hoffmann ^[6] ; Ioannis,Iakovou ^[7] ; Jasna,Mihailovic ^[8] ; Bernd J,Krause ^[9] ; Werner,Langsteger ^[10] ; Frederik A,Verburg ^[11] ; Markus,Luster ^[12] ; EANM and the EANM Thyroid Committee ^[13]

作者单位： Department of Nuclear Medicine, PET/CT & Thyroid Centre, Oncology Institute of Southern Switzerland, CH-6500, Bellinzona, Switzerland. giorgiomednuc@libero.it. ^[1] Tirocenter, Nuclear Medicine, Adnan Saygun caddesi, Nispetiye, Besiktas, Istanbul, Turkey. ^[2] Humanitas Research Hospital, Department of Nuclear Medicine, Rozzano, Milan, Italy. ^[3] Humanitas University, Rozzano, Milan, Italy. ^[4] Bank of Cyprus Oncology Center, Nuclear Medicine Department, Nicosia, Cyprus. ^[5] Department of Nuclear Medicine, PET/CT & Thyroid Centre, Oncology Institute of Southern Switzerland, CH-6500, Bellinzona, Switzerland. ^[6] Radiology Center, Nuclear Medicine, Vienna, Austria. ^[7] Department of Nuclear Medicine, Aristotle University, Papageorgiou Hospital, Thessaloniki, Greece. ^[8] Oncology Institute of Vojvodina, Department of Nuclear Medicine, Sremska Kamenica, Serbia. ^[9] Department of Nuclear Medicine, Rostock University Hospital, Rostock, Germany. ^[10] PET-CT Center Linz, Department of Nuclear Medicine & Endocrinology, Linz, Austria. ^[11] Department of Nuclear Medicine, RWTH University Hospital Aachen, Aachen, Germany. ^[12] Department of Nuclear Medicine, University Hospital Marburg, Marburg, Germany. ^[13]